TY  - CONF

T1  - Combination vs single agent treatment: The effects of zoledronic acid+/−doxorubicin on breast tumour growth in bone prior to development of osteolytic bone disease

JO  - Bone

PY  - 2011/01/01

AU  - Brown* HK

AU  - Ottewell PD

AU  - Evans CA

AU  - Coleman RE

AU  - Holen I

ED  - 

DO  - DOI: 10.1016/j.bone.2010.10.116

PB  - Elsevier BV

VL  - 48

IS  - 1

SP  - S41

EP  - S41

Y2  - 2024/12/22

ER  -